Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87534 refers to the detection of the infectious agent HIV-1 through nucleic acid techniques, specifically utilizing a direct probe method. This procedure is essential for identifying the presence of HIV-1, a virus that significantly impacts the immune system by targeting and destroying CD4 T-cells, which are crucial for immune function. The transmission of HIV-1 can occur through various means, including sexual contact, unscreened blood transfusions, sharing of needles, and from mother to child during pregnancy or breastfeeding. The identification of HIV-1 is critical for diagnosing and managing the infection, as it can lead to Acquired Immunodeficiency Syndrome (AIDS) if left untreated. The testing process involves obtaining a blood sample, where the direct probe technique is employed to detect the viral nucleic acids. Although direct probes are less commonly used due to their requirement for specimen culture, they play a role in the overall diagnostic framework. Alternative methods, such as amplified probe techniques and quantification, are also available for more sensitive detection and measurement of HIV-1, particularly when the viral load is low. Understanding the nuances of these testing methods is vital for healthcare professionals involved in the diagnosis and treatment of HIV-1 infections.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 87534 is indicated for the detection of HIV-1 in patients who may be at risk for HIV infection. The following conditions and situations warrant the use of this testing method:
The procedure for CPT® Code 87534 involves several critical steps to ensure accurate detection of HIV-1. The following outlines the procedural steps:
After the procedure associated with CPT® Code 87534, the patient may be advised on follow-up testing and counseling based on the results. If the test is positive, further evaluation and treatment options will be discussed, including antiretroviral therapy. Patients may also be referred for additional support services, including mental health counseling and support groups. It is essential to monitor the patient's health and response to treatment, particularly if they are diagnosed with HIV-1, to manage the infection effectively and prevent progression to AIDS.
| Short Descr | HIV-1 DNA DIR PROBE | Medium Descr | IADNA HIV-1 DIRECT PROBE TECHNIQUE | Long Descr | Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, direct probe technique | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| 1998-01-01 | Added | First appearance in code book in 1998. |
Get instant expert-level medical coding assistance.